Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of Graves' hyperthyroidism.

J Orgiazzi1

  • 1Service de Médecine Interne, Centre Hospitalier Lyon-Sud, France.

Endocrinology and Metabolism Clinics of North America
|June 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.

Journal of endocrinological investigation·2020
Same author

Are dietary reports in a case-control study on thyroid cancer biased by risk perception of Chernobyl fallout?

Revue d'epidemiologie et de sante publique·2017
Same author

Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.

Clinical endocrinology·2016
Same author

[Best practices guideline for the use of neck ultrasonography and echo-guided techniques in the management of differentiated thyroid cancers of the follicular type. Société Française d’Endocrinologie.Groupe de Recherche sur la Thyroïde].

Annales d'endocrinologie·2011
Same author

Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin.

Annales d'endocrinologie·2011
Same author

[A new possible phenotype of carbimazole embryopathy: A case report].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2010

Managing Graves' disease hyperthyroidism requires a strategic approach. While antithyroid drugs are used, long-term treatment and patient adherence are challenging, often necessitating ablative therapies like radioactive iodine or surgery.

Area of Science:

  • Endocrinology
  • Internal Medicine
  • Thyroidology

Background:

  • Graves' disease is a chronic autoimmune disorder causing hyperthyroidism.
  • Current management strategies for hyperthyroidism present challenges in patient adherence and treatment adaptation.
  • Long-term antithyroid drug therapy (≥18 months) is common, but predicting remission remains unreliable.

Purpose of the Study:

  • To review the current landscape of Graves' disease hyperthyroidism management.
  • To discuss the limitations of antithyroid drug therapy and the role of ablative treatments.
  • To highlight the need for innovative therapeutic approaches.

Main Methods:

  • Review of existing literature on Graves' disease management.
  • Comparison of therapeutic modalities including antithyroid drugs, radioactive iodine, and surgery.

Related Experiment Videos

  • Discussion of treatment efficacy, side effects, and patient outcomes.

    • Main Results:

    • Antithyroid drug treatment requires long durations and patient adherence is crucial.
    • Predictive factors for remission with medical treatment are not yet reliable.
    • Radical treatments, such as radioactive iodine (131I) and surgery, are often necessary.
    • Radioactive iodine therapy generally carries a lower risk of subsequent hypothyroidism compared to surgery.

    Conclusions:

    • Effective Graves' disease hyperthyroidism management necessitates a clear strategy and patient engagement.
    • Current medical treatments have limitations, often requiring consideration of ablative therapies.
    • Further research is needed to develop innovative, personalized, and pathophysiologically-guided treatments for Graves' disease.